Antitumor activity of five new platinum complexes having a glycolate leaving ligand.
In an attempt to develop a new anticancer platinum complex with greater or equivalent antitumor activity but reduced side effects compared with cisplatin (CDDP), a series of new platinum complexes having a glycolate leaving ligand was synthesized. Among them, five complexes were selected for further...
| Main Authors: | , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Korean Academy of Medical Sciences
1995
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3054062/ |